|
Discovery of Potent Antagonists of the Antiapoptotic Protein XIAP for the Treatment of Cancer
|
journal
|
August 2004 |
|
Emerging Utility of Fluorosulfate Chemical Probes
|
journal
|
June 2018 |
|
Genetically Encoding Fluorosulfate-l-tyrosine To React with Lysine, Histidine, and Tyrosine via SuFEx in Proteins in Vivo
|
journal
|
March 2018 |
|
Proximity-enabled bioreactivity to generate covalent peptide inhibitors of p53–Mdm4
|
journal
|
January 2016 |
|
Covalent vs. Non‐Covalent Inhibition: Tackling Drug Resistance in EGFR – A Thorough Dynamic Perspective
|
journal
|
February 2019 |
|
Introduction of a Crystalline, Shelf-Stable Reagent for the Synthesis of Sulfur(VI) Fluorides
|
journal
|
January 2018 |
|
A study of the reactivity of S(VI)–F containing warheads with nucleophilic amino-acid side chains under physiological conditions
|
journal
|
January 2017 |
|
PHENIX: a comprehensive Python-based system for macromolecular structure solution
|
journal
|
January 2010 |
|
Structure-Based Design of Covalent Siah Inhibitors
|
journal
|
August 2013 |
|
IAP proteins: blocking the road to death's door
|
journal
|
June 2002 |
|
Isothermal Analysis of ThermoFluor Data can readily provide Quantitative Binding Affinities
|
journal
|
February 2019 |
|
“Inverse Drug Discovery” Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates
|
journal
|
December 2017 |
|
MolProbity : all-atom structure validation for macromolecular crystallography
|
journal
|
December 2009 |
|
Structure-based design and synthesis of covalent-reversible inhibitors to overcome drug resistance in EGFR
|
journal
|
June 2015 |
|
Phaser crystallographic software
|
journal
|
July 2007 |
|
A Fluorogenic Aryl Fluorosulfate for Intraorganellar Transthyretin Imaging in Living Cells and in Caenorhabditis elegans
|
journal
|
June 2015 |
|
Strategies for Targeting KRAS: A Challenging Drug Target
|
journal
|
June 2022 |
|
Progress with covalent small-molecule kinase inhibitors
|
journal
|
March 2018 |
|
Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain
|
journal
|
September 2016 |
|
Potent, Orally Bioavailable Diazabicyclic Small-Molecule Mimetics of Second Mitochondria-Derived Activator of Caspases
|
journal
|
December 2008 |
|
A Small Molecule Smac Mimic Potentiates TRAIL- and TNF -Mediated Cell Death
|
journal
|
September 2004 |
|
Design, Synthesis, and Biological Activity of a Potent Smac Mimetic That Sensitizes Cancer Cells to Apoptosis by Antagonizing IAPs
|
journal
|
September 2006 |
|
KRAS G12C Mutations in NSCLC: From Target to Resistance
|
journal
|
May 2021 |
|
Design, Synthesis, and Evaluation of Potent, Nonpeptidic Mimetics of Second Mitochondria-Derived Activator of Caspases
|
journal
|
January 2009 |
|
Cysteinome: The first comprehensive database for proteins with targetable cysteine and their covalent inhibitors
|
journal
|
September 2016 |
|
Coot model-building tools for molecular graphics
|
journal
|
November 2004 |
|
Covalent Inhibitors of Protein–Protein Interactions Targeting Lysine, Tyrosine, or Histidine Residues
|
journal
|
May 2019 |
|
New drug design with covalent modifiers
|
journal
|
January 2016 |
|
Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)
|
journal
|
March 2012 |
|
The Design of Covalent Allosteric Drugs
|
journal
|
January 2015 |
|
Structure-based design of targeted covalent inhibitors
|
journal
|
January 2018 |
|
Identification and Characterization of an Irreversible Inhibitor of CDK2
|
journal
|
September 2015 |
|
A Smac Mimetic Rescue Screen Reveals Roles for Inhibitor of Apoptosis Proteins in Tumor Necrosis Factor-α Signaling
|
journal
|
December 2007 |
|
Synergistic effects of IAP inhibitor LCL161 and paclitaxel on hepatocellular carcinoma cells
|
journal
|
September 2014 |
|
The FRB Domain of mTOR: NMR Solution Structure and Inhibitor Design,
|
journal
|
August 2006 |
|
Beyond cysteine: recent developments in the area of targeted covalent inhibition
|
journal
|
June 2018 |
|
Smac mimetic compound LCL161 sensitizes esophageal carcinoma cells to radiotherapy by inhibiting the expression of inhibitor of apoptosis protein
|
journal
|
October 2013 |
|
Covalent Inhibition in Drug Discovery
|
journal
|
March 2019 |
|
Design, Synthesis, and Evaluation of a Potent, Cell-Permeable, Conformationally Constrained Second Mitochondria Derived Activator of Caspase (Smac) Mimetic
|
journal
|
November 2006 |
|
Nuclear Magnetic Resonance Fragment-Based Identification of Novel FKBP12 Inhibitors
|
journal
|
November 2007 |
|
Discovery of aminopiperidine-based Smac mimetics as IAP antagonists
|
journal
|
February 2012 |
|
Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue
|
journal
|
June 2016 |
|
Orally Bioavailable Antagonists of Inhibitor of Apoptosis Proteins Based on an Azabicyclooctane Scaffold
|
journal
|
February 2009 |
|
Design of Potent pan-IAP and Lys-Covalent XIAP Selective Inhibitors Using a Thermodynamics Driven Approach
|
journal
|
June 2018 |
|
Inhibitor of Apoptosis Protein (IAP) Antagonists in Anticancer Agent Discovery: Current Status and Perspectives
|
journal
|
January 2019 |
|
Requirement of Both the Second and Third BIR Domains for the Relief of X-linked Inhibitor of Apoptosis Protein (XIAP)-mediated Caspase Inhibition by Smac
|
journal
|
December 2003 |
|
Lysine Covalent Antagonists of Melanoma Inhibitors of Apoptosis Protein
|
journal
|
October 2021 |
|
Broad-Spectrum Kinase Profiling in Live Cells with Lysine-Targeted Sulfonyl Fluoride Probes
|
journal
|
January 2017 |
|
Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells
|
journal
|
August 2012 |
|
Structure‐based design and molecular profiling of Smac‐mimetics selective for cellular IAPs
|
journal
|
August 2018 |
|
Assessing Lysine and Cysteine Reactivities for Designing Targeted Covalent Kinase Inhibitors
|
journal
|
April 2019 |
|
Nonpeptidic and Potent Small-Molecule Inhibitors of cIAP-1/2 and XIAP Proteins
|
journal
|
August 2010 |
|
A Potent Bivalent Smac Mimetic (SM-1200) Achieving Rapid, Complete, and Durable Tumor Regression in Mice
|
journal
|
May 2013 |
|
Aryl-fluorosulfate-based Lysine Covalent Pan-Inhibitors of Apoptosis Protein (IAP) Antagonists with Cellular Efficacy
|
journal
|
September 2019 |
|
Aryl fluorosulfate analogues as potent antimicrobial agents: SAR, cytotoxicity and docking studies
|
journal
|
December 2018 |
|
Antagonism of c-IAP and XIAP Proteins Is Required for Efficient Induction of Cell Death by Small-Molecule IAP Antagonists
|
journal
|
June 2009 |
|
Sulfonyl fluorides as privileged warheads in chemical biology
|
journal
|
January 2015 |
|
Phase I Dose-Escalation Study of LCL161, an Oral Inhibitor of Apoptosis Proteins Inhibitor, in Patients With Advanced Solid Tumors
|
journal
|
October 2014 |
|
Structural basis of IAP recognition by Smac/DIABLO
|
journal
|
December 2000 |
|
HTS by NMR for the Identification of Potent and Selective Inhibitors of Metalloenzymes
|
journal
|
January 2018 |
|
HTS by NMR of Combinatorial Libraries: A Fragment-Based Approach to Ligand Discovery
|
journal
|
January 2013 |
|
A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment
|
journal
|
March 2011 |
|
A DNA‐Encoded Library of Chemical Compounds Based on Common Scaffolding Structures Reveals the Impact of Ligand Geometry on Protein Recognition
|
journal
|
June 2018 |
|
Distinct BIR Domains of cIAP1 Mediate Binding to and Ubiquitination of Tumor Necrosis Factor Receptor-associated Factor 2 and Second Mitochondrial Activator of Caspases
|
journal
|
January 2006 |
|
The resurgence of covalent drugs
|
journal
|
April 2011 |
|
Drug discovery for a new generation of covalent drugs
|
journal
|
May 2012 |
|
Initial testing (stage 1) of LCL161, a SMAC mimetic, by the pediatric preclinical testing program
|
journal
|
June 2011 |
|
Targeted Covalent Inhibitors for Drug Design
|
journal
|
August 2016 |
|
KRAS-Targeted Therapies in Advanced Solid Cancers: Drug the Undruggable?
|
journal
|
June 2021 |
|
Covalent Inhibition in Drug Discovery: Filling the Void in Literature
|
journal
|
October 2018 |
|
Uncoupling of the Signaling and Caspase-inhibitory Properties of X-linked Inhibitor of Apoptosis
|
journal
|
March 2004 |
|
hBfl-1/hNOXA Interaction Studies Provide New Insights on the Role of Bfl-1 in Cancer Cell Resistance and for the Design of Novel Anticancer Agents
|
journal
|
December 2016 |
|
Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology
|
journal
|
December 2018 |
|
The Cysteinome of Protein Kinases as a Target in Drug Development
|
journal
|
February 2018 |
|
Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Discovery of a Non-Alanine Lead Series with Dual Activity Against cIAP1 and XIAP
|
journal
|
August 2015 |
|
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
|
journal
|
May 2008 |
|
Sulfur(VI) Fluoride Exchange (SuFEx): Another Good Reaction for Click Chemistry
|
journal
|
August 2014 |
|
IAP family proteins---suppressors of apoptosis
|
journal
|
February 1999 |
|
Developing Irreversible Inhibitors of the Protein Kinase Cysteinome
|
journal
|
February 2013 |
|
Lysine-Targeting Covalent Inhibitors
|
journal
|
October 2017 |
|
Rapid labelling and covalent inhibition of intracellular native proteins using ligand-directed N-acyl-N-alkyl sulfonamide
|
journal
|
May 2018 |
|
A Fragment-Based Approach for the Discovery of Isoform-Specific p38α Inhibitors
|
journal
|
April 2007 |
|
Design and Synthesis of Potent Inhibitor of Apoptosis (IAP) Proteins Antagonists Bearing an Octahydropyrrolo[1,2- a ]pyrazine Scaffold as a Novel Proline Mimetic
|
journal
|
January 2013 |
|
Enthalpy-Based Screening of Focused Combinatorial Libraries for the Identification of Potent and Selective Ligands
|
journal
|
November 2017 |
|
Nmr in drug discovery
|
journal
|
March 2002 |
|
Fragment-Based Design of Small Molecule X-Linked Inhibitor of Apoptosis Protein Inhibitors
|
journal
|
October 2008 |
|
High-Throughput Screening (HTS) by NMR Guided Identification of Novel Agents Targeting the Protein Docking Domain of YopH
|
journal
|
November 2015 |
|
Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies
|
journal
|
September 2015 |
|
Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard
|
journal
|
December 2007 |
|
Drug discovery considerations in the development of covalent inhibitors
|
journal
|
January 2014 |
|
Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain
|
journal
|
December 2000 |
|
NMR-Based Approaches for the Identification and Optimization of Inhibitors of Protein–Protein Interactions
|
journal
|
February 2014 |
|
High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs Antagonists
|
journal
|
July 2015 |
|
Design, Synthesis, and Characterization of a Potent, Nonpeptide, Cell-Permeable, Bivalent Smac Mimetic That Concurrently Targets Both the BIR2 and BIR3 Domains in XIAP
|
journal
|
December 2007 |
|
DNA-encoded chemical libraries - achievements and remaining challenges
|
journal
|
May 2018 |
|
Targeting Drug Resistance in EGFR with Covalent Inhibitors: A Structure-Based Design Approach
|
journal
|
August 2015 |